The company plans to launch a test for gram-negative bacteria next, and will work with developers and freelancers to develop additional assay content
Based on iCubate's Amplicon-Rescued Multiplex PCR technology, the iC-GPC assay is the first of the company's portfolio's to earn CE mark.
The iC-System is based on on iCubate's amplicon-rescued multiplex PCR technology, which detects multiple pathogens simultaneously.
Researchers sequenced samples from children with eczema and found that one S. aureus strain dominates during severe disease flares, though it varies by patient.
Researchers have isolated Staphylococcus saprophyticus and Gardnerella vaginalis from an 800-year-old skeleton, New Historian reports.
Researchers from the CDC and Georgia Tech tested the efficacy of using whole-genome shotgun sequencing to diagnose food-borne pathogens in outbreaks.
Two of the firm's assays were evaluated in posters presented at a recent conference, demonstrating good performance relative to commonly used non-molecular methods.
Researchers examined virulence, resistance, and transmission patterns in genome sequence data for more than 300 invasive Staphylococcus aureus isolates from Europe.
Cepheid will create Xpert cartridge tests to detect S. aureus and P. aeuginosa, to be used in clinical trials for biologics intended to prevent pneumonia.
In PLOS this week: recombination density-based method for calibrating human mutation rates, pathogen-typing approach using solid-state nanopores, and more.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.